Nirsevimab may offer infants stronger protection against severe respiratory syncytial virus than maternal vaccination, ...
This week's report explores the pharmaceutical industry’s evolution toward resilient, scalable systems that prioritize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results